AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
(From Asia Pulse)
(Full text of statement. Contact details below.)
EAST HILLS, N.Y.--(BUSINESS WIRE)--Aug. 17, 2005--As cord blood increasingly takes front and center stage as a critical source of stem cells for transplants, it has driven the need for consistent quality standards to ensure the safety and efficacy of this life-saving therapy. The newly published results of the landmark COBLT (Cord Blood Transplantation) Study advance standards for cord blood collection, processing and cryopreservation. Along with defining standard operating procedures, Pall Corporation (NYSE: PLL) products were the only sets used in the study for the collection, processing and cryopreservation of stem cells from umbilical cord blood.
Cord blood is now widely recognized as …